Reduction in blood pressure in patients treated with vildagliptin as monotherapy or in combination with metformin for type 2 diabetes

被引：0
|
作者：
Nathwani, Ameet
Lebeaut, Alexandre
Byiers, Stuart
Gimpelewicz, Claudio
Chang, Ih
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A113 / A113
页数：1
相关论文
共 50 条
  • [41] Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial
    Schweizer, A.
    Dejager, S.
    Bosi, E.
    DIABETES OBESITY & METABOLISM, 2009, 11 (08): : 804 - 812
  • [42] Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes
    Pi-Sunyer, F. Xavier
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 132 - 138
  • [43] Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naive Patients with Type 2 Diabetes: Comparison with Metformin
    Goeke, B.
    Hershon, K.
    Kerr, D.
    Calle Pascual, A.
    Schweizer, A.
    Foley, J.
    Shao, Q.
    Dejager, S.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (12) : 892 - 895
  • [44] Secondary Metformin Monotherapy Failure in Type 2 Diabetes Mellitus Patients
    Weiss, Tracey
    Iglay, Kristy
    Verma, Priya
    Rajpathak, Swapnil
    Yang, Lingfeng
    Blonde, Lawrence
    DIABETES, 2019, 68
  • [45] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
  • [46] Lack of pharmacokinetic interaction between vildagliptin and metformin in patients with type 2 diabetes.
    He, YL
    Sabo, R
    Picard, F
    Wang, Y
    Campestrini, J
    Herron, J
    Ligueros-Saylan, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P62 - P62
  • [47] VIRTUE study: effects of vildagliptin versus sulphonylureas as monotherapy or combined with metformin in Muslim patients with type 2 diabetes fasting during Ramadan
    Shaltout, I.
    Pathan, F.
    Medlej, R.
    Al-Arouj, M.
    Hassoun, A. A. K.
    Chawla, M. S.
    Knap, D.
    Vaz, J. A.
    DIABETOLOGIA, 2014, 57 : S359 - S359
  • [48] Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin
    Suzuki, Luka
    Kanazawa, Akio
    Uzawa, Hirotsugu
    Osonoi, Yusuke
    Masuyama, Atushi
    Azuma, Kosuke
    Takeno, Kageumi
    Takayanagi, Naoko
    Sato, Junko
    Someya, Yuki
    Komiya, Koji
    Goto, Hiromasa
    Mita, Tomoya
    Ikeda, Fuki
    Ogihara, Takeshi
    Shimizu, Tomoaki
    Ohmura, Chie
    Saito, Miyoko
    Osonoi, Takeshi
    Watada, Hirotaka
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) : 1921 - 1928
  • [49] Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes
    Scherbaum, W. A.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 1 - 2
  • [50] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
12345